文献速递乳房整形与再造美容整形

上位蒂短瘢痕乳房固定术联合隆乳:1217例连续病例的10年回顾

Superiorly Based Short-Scar Mastopexy Augmentation: A 10-Year Review of 1217 Consecutive Cases.
PubMed 文献 · Plast Reconstr Surg · 2023-01-02

该研究回顾了2005至2015年间由两位资深术者完成的1217例一期上位蒂短瘢痕乳房固定术联合隆乳,总体修整率为4.8%,既往乳房手术者修整率高于 virgin 乳房组织者(10.4% vs 3.8%,P=0.0005),平均随访39个月,作者认为该术式可安全、可预测地一期完成且并发症与再手术率低。

要点

  • 总体修整率为4.8%,58例修整中86%为单纯假体或假体腔相关,7%为单纯组织相关。
  • 既往乳房手术者修整率10.4% vs virgin 乳房组织者3.8%(P=0.0005)。
  • 出现1例部分乳头坏死,无急诊再手术、假体丢失、假体外露或重大伤口裂开。

核心结论

  • 作者的方法经过优化以最大化美学、持久性、一致性与手术效率并减少并发症。
  • 该研究显示一期即可获得安全且可预测的结果,并发症率与再手术率低。

研究设计与样本

  • 10年回顾性综述,纳入2005至2015年间所有乳房美容手术。
  • 两位资深术者(S.H.W.与H.C.W.)完成1217例一期、上位蒂、短瘢痕乳房固定术联合隆乳。
  • 数据与文献中其他已发表系列进行对照评估。

主要发现

  • 总体修整率为4.8%。
  • 既往乳房手术者较 virgin 乳房组织者统计学上更可能需要修整(10.4% vs 3.8%;P=0.0005)。
  • 平均随访39个月。
  • 28%的修整在原始手术后超过2年进行;16%在超过6年后进行。
  • 58例修整病例中,86%为单纯假体或假体腔相关;7%为单纯组织相关。

关键数值与推荐

  • 所有修整均纳入,不论手术范围或时机。
  • 出现1例部分乳头坏死。
  • 无急诊再手术、假体丢失、假体外露或重大伤口裂开病例。

临床怎么用

  • 作者认为其方法可在一期获得安全且可预测的结果,并发症率与再手术率低。
  • 证据等级为治疗性,IV级。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mastopexy augmentation is a challenging procedure, and a technique to create desirable, consistent, predictable results with a low rate of problems has not been well standardized. The inherent difficulty lies in competing surgical maneuvers. This study sought to evaluate the authors' experience and describe the key concepts and steps that allow safe, efficient, predictable results with low complication and long-term reoperation rates. METHODS: A 10-year retrospective review of all aesthetic breast operations between 2005 and 2015 was performed. Two senior surgeons (S.H.W. and H.C.W.) performed 1217 one-stage, superiorly based, short-scar mastopexy augmentation procedures. The data were evaluated in the context of other published series in the literature. RESULTS: The overall revision rate was 4.8%. Patients who had undergone prior breast surgery were statistically more likely to require a revision compared with patients who had virgin breast tissue (10.4% versus 3.8%; P = 0.0005). Average follow-up was 39 months. Twenty-eight percent of revisions were performed more than 2 years after the original surgery; 16% were performed more than 6 years later. All revisions were included, regardless of procedure scope or timing. Of the 58 revision cases, 86% were purely implant or implant-pocket related; 7% were purely tissue related. There was one case of partial nipple necrosis. There were no cases of emergent reoperation, implant loss, implant exposure, or major wound dehiscence. CONCLUSIONS: The authors' approach has been refined to maximize aesthetics, longevity, consistency, and surgical efficiency, and to minimize complications. This study demonstrates that safe and predictable results can be attained in one stage with low complication and reoperation rates. . CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Wall SH, Claiborne JR, Wall HC, et al. Superiorly Based Short-Scar Mastopexy Augmentation: A 10-Year Review of 1217 Consecutive Cases. Plast Reconstr Surg. 2023. PMID: 36728622. doi:10.1097/PRS.0000000000010129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。